What Kind Of Investors Own Most Of Baidu, Inc. (NASDAQ:BIDU)?
A look at the shareholders of Baidu, Inc. (NASDAQ:BIDU) can tell us which group is most powerful. Institutions will… …read more […]
A look at the shareholders of Baidu, Inc. (NASDAQ:BIDU) can tell us which group is most powerful. Institutions will… …read more […]
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Rick Newman discuss the new rollout of the Ford Bronco vehicles. …read more […]
In California, confirmed cases of COVID-19 are on the rise. Los Angeles ER Doctor Dr. Ellice joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss the rise in cases, who is getting hit hardest by the recent surge, the possibility of school in the fall going digital across the nation and more. …read more […]
Yahoo Finance’s Emily McCormick breaks down earnings reports from JPMorgan, Wells Fargo and Citigroup. …read more […]
(Bloomberg) — Wells Fargo & Co. plummeted after reporting its first quarterly loss since 2008 as loan-loss provisions soared with the bank expecting a more severe downturn from the coronavirus pandemic.The firm set aside a record $9.5 billion for credit losses, about $4 billion more than analysts had expected. Wells Fargo executives had warned they would earmark more for soured loans than the first quarter’s $4 billion as the pandemic continues to rage throughout the U.S. and weigh on companies and workers.The San Francisco-based lender also cut its dividend to 10 cents a share from 51 cents. Wells Fargo said …read more […]
The San Francisco-based bank also cut its dividend for the third quarter to 10 cents per share from 51 cents previously to reflect the U.S. Federal Reserve’s recent curbs on bank dividends. Net interest income fell 18% from the prior period, as interest rates have fallen to near zero. …read more […]
Shares in IMV Inc. (IMV) are spiking 134% in Tuesday’s pre-market trading after the clinical-stage biopharma company said it made “rapid progress” in developing its candidate vaccine to prevent COVID-19 infection.The stock surged to $4 in pre-market trading as IMV said that it was working closely with regulatory agencies and its partners to initiate clinical studies as quickly as possible. The plan for the Phase 1 clinical study, agreed with Health Canada, is a randomized controlled study, assessing the safety and immunogenicity of its vaccine candidate DPX-COVID-19, to be conducted in 84 healthy adults across two age cohorts.DPX-COVID-19, is based …read more […]
Tesla Inc (TSLA) has met with officials from a district in the city of Chongqing in southwestern China to discuss “accelerating projects”, the Liangjiang New Area said on Tuesday, as reported by Reuters.According to the report, officials held meetings with Tesla Vice-president Tao Lin, whose visit was reportedly welcomed by government official Duan Chenggang to “promote cooperation.”Reuters also reports unidentified sources cited by the China Securities Journal stating that cooperation could refer to sales and maintenance centers rather than factories. Last year Tesla opened its first plant outside the US in Shanghai.Shares in Tesla are climbing 6% in Tuesday’s pre-market …read more […]
Biogen (BIIB), in collaboration with Eisai, and the Alzheimer’s Clinical Trials Consortium, has initiated a new global Phase 3 clinical study (AHEAD 3-45) with BAN2401, an anti-amyloid beta (Aβ) protofibril antibody.The study will evaluate the therapeutic effect of BAN2401 on the progression of Alzheimer’s disease in individuals in preclinical (asymptomatic) stages of the disease. These patients are clinically normal and have intermediate or elevated levels of amyloid in their brains.The AHEAD 3-45 program consists of two trials, A3 and A45, which aim to evaluate the potential of BAN2401 to reduce accumulation of harmful amyloid beta aggregates in the brain and …read more […]
Stock futures opened slightly higher Monday evening as investors looked ahead of a slew of earnings results from big banks Tuesday and later this week. …read more […]
(Bloomberg) — China will impose unspecified sanctions on defense contractor Lockheed Martin Corp. after the U.S. approved a possible $620 million deal to supply missile parts to Taiwan, marking the latest in a volley of punitive actions by the superpowers as relations grow colder.“China firmly opposes U.S. arms sales to Taiwan,” Chinese Foreign Ministry spokesman Zhao Lijian said at a briefing in Beijing on Tuesday. “We will impose sanctions on the main contractor of this arms sale, Lockheed Martin,” he said, without elaborating on what form the sanctions may take.The move comes as tensions grow between the U.S. and China …read more […]
Delta Air Lines on Tuesday reported an adjusted pre-tax loss of $3.9 billion in the second quarter, as the COVID-19 pandemic that’s hammered the airline industry ravaged the company’s revenue. …read more […]
JPMorgan boosts its credit reserves as the coronavirus crisis worsens worldwide. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.